Explore All 789 Divestiture Life Science Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | January 13, 2020 |
| Target | Assertio Therapeutics - Gralise Business |
| Sector | Life Science |
| Buyer(s) | Alvogen |
| Sellers(s) | Assertio |
| Deal Type | Divestiture |
| Deal Value | 128M USD |
FILTER BY
Alvogen is a multinational pharmaceuticals company focused on developing, manufacturing, and distributing generic, brand, over-the-counter brands (OTC), and biosimilar products. Alvogen was founded in 2009 and is based in Pine Brook, New Jersey.
| Deal Context for Buyer | # |
|---|---|
| Overall | 8 of 8 |
| Sector: Life Science | 8 of 8 |
| Type: Divestiture | 4 of 4 |
| State: California | 1 of 1 |
| Country: United States | 3 of 3 |
| Year: 2020 | 1 of 1 |
| Size (of disclosed) | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-10-25 |
Alvogen CEE
Poland Alvogen CEE markets over 200 generic and over-the-counter products across multiple therapeutic areas, consisting of highly recognized brands like Lactacyd, Persen, EuBiotic and many more with leading market positions in 14 key markets across CEE including; Russia, Romania, Bulgaria, Hungary, Poland and Balkan markets. |
Sell | - |
| Category | Company |
|---|---|
| Founded | 1995 |
| Sector | Life Science |
| Employees | 58 |
| Revenue | 125M USD (2024) |
Assertio is a pharmaceutical company focused on products to treat pain and other central nervous system (CNS) conditions. Assertio was founded in 1995 and is based in Lake Forest, Illinois.
| Deal Context for Seller | # |
|---|---|
| Overall | 2 of 3 |
| Sector: Life Science | 1 of 2 |
| Type: Divestiture | 2 of 3 |
| State: California | 1 of 2 |
| Country: United States | 2 of 3 |
| Year: 2020 | 1 of 2 |
| Size (of disclosed) | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-11-04 |
Depomed - Diabetes Royalty Rights
United States Depomed - Diabetes Royalty Rights is a provider of medical products. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-02-06 |
Assertio Therapeutics - NUCYNTA
California, United States Assertio Therapeutics, Inc. - NUCYNTA is a strong prescription pain medicine that contains an opioid (narcotic) that is used to manage short-term (acute) pain in adults when other pain treatments, such as non-opioid pain medicines, do not treat your pain well enough or you cannot tolerate them. |
Sell | $375M |
